StockWatch
·

Indigo Paints Ltd Q2 FY27 Results

INDIGOPNTSQ2 FY27 Results
Filing
Result:Weak· Market: Crashed#Margin squeeze#Cost led

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue358.753.0%15.0%
Total Income360.925.0%14.6%
Expenditure344.276.3%22.4%
PBT16.6670.3%50.7%
Net Profit13.3967.9%47.0%
OPM8.63%8.15pp6.28pp
NPM3.71%7.27pp4.30pp
EPS2.8068.0%46.9%
View full financials

Revenue grew a healthy 15% YoY but costs rose faster, crushing OPM from 14.9% to 8.6% and driving a 47% PAT decline — a clear cost-led margin squeeze rather than a core business issue, with no consensus estimate found to judge beat/miss.

INDIGO PAINTS · Q2 FY27 · THE VERDICT

Growth masked by an inventory echo; H2 should clear the air

Revenue grew 15% but profit fell 47%, courtesy of high-cost raw material inventory bought at the peak and expensed in Q2. The real story sits in the half-year numbers and October's recovery signal.

06 Nov 2026 · 6 min read
Reported PAT

₹13.4 Cr

-47.0% YoY

H1 PAT (cleaner view)

₹56.2 Cr

+7.4% YoY

Reported Revenue

₹358.8 Cr

+15.0% YoY

The Q2 result lands with a puzzle: revenue climbs 15% year-on-year, a solid beat on industry growth, yet profit crashes 47%. The headline reads like a stumble. The call explains what happened — and why it wasn't.

The inventory echo

Indigo has been caught in a raw material price wave. In March–April 2026, crude spiked and paint feedstocks soared; the company bought inventory at the peak. That high-cost stock sat in the books and got expensed into Q2 COGS, depressing gross margin by 660 basis points. Management calls it 'the quirk of accountancy' — and it's real, not phantom. But it masks the operational picture. Q1 enjoyed the reverse phenomenon: low-cost inventory from before the spike got expensed into Q1 COGS, inflating EBITDA +42% year-on-year. Q2 hit the inverse. Together, H1 tells a steadier story: EBITDA margin 13.4%, down 170 bps, with PAT up 7.4% year-on-year. That's the organic run.

EBITDA growth YoY, %
-42-11205142Q1 FY27-33Q2 FY2714H1 FY27
The inventory swing: Q1 inflated by low-cost stock, Q2 deflated by high-cost stock. H1 normalizes both.

Margin breakdown: where the 660 bps fell

Gross margin collapsed 660 bps. Management attributed the decline to two drivers:
DriverImpact (bps)Detail
High-cost inventory expensing400Raw materials bought March–April at peak crude prices; expensed into Q2 COGS as production ran.
Product mix unfavorable250Monsoon quarter weakness in exterior paints (higher margin); emulsions (lower margin) stronger.

Management's claims, graded

On the call, management made several key assertions. Here's how they stack up:

Gross margin collapse is entirely inventory accounting, not operational failure.

Supported. Inventory accounts ~400 bps of 660 bps; mix is the remainder.

Q2 stand-alone revenue +14.1% YoY; industry grew 12–14%.

Supported. Consolidated +15% per delivered results; marginal outperformance.

October 2026 saw record monthly sales and highest Y-on-Y growth in 3–4 years.

Unverified. Stated post-Q2 close (Nov 2). Not in Q2 results; early signal of H2 recovery.

Jodhpur 90KL water-based plant fully operational by end-November 2026.

Supported on timeline. Trial started late Sept; target end-Nov. Minor fuzziness acknowledged.

No profitability shocks expected Q3 onwards; inventory is behind us.

Overstated. Contingent on crude $110–115 stability. Management: 'If crude goes through the roof, I can't predict.'

What changed on this call

The inventory burden is now explicit (prior call was vague). August already showed margin recovery as high-cost stock cleared; October's record sales claim—highest monthly Y-on-Y growth in 3–4 years—is a tangible early signal of H2 momentum. Guidance stance unchanged: no formal FY27 revenue target (prior call set the same tone), aggressive growth with accepted margin compression. Hemant Jalan continues dodging numeric targets ('I hesitate to give a number'), citing past over-commitment and current macro uncertainty. It's learning-and-caution, but also a guardrail on execution confidence.

The bull–bear ledger
  • Revenue +15% YoY, outpacing industry 12–14%

  • PAT -47% is inventory accounting shock, not operational failure

  • H1 EBITDA margin (13.4%, -170 bps) cleaner than Q2 in isolation

  • October record sales signal H2 momentum emerging

  • Jodhpur 90KL plant eliminates capex risk for 3 years

  • Dealer network (19,730) and reach (28 states, 6 plants) are structural

  • Price hikes (Nov 1 + Nov 21) risk volume elasticity in weak season

  • Geopolitical crude risk could repeat Q2-style margin shock

  • Management avoids numeric guidance; execution caution

  • Local competitors recovering ground (management's own words)

Risks, ranked by concern to a holder

What could derail the H2 recovery narrative:

Geopolitical crude spike (>$120)

High

Unhedgeable. Repeat of March–April surge loads high-cost inventory into Q3 books and repeats margin shock. Management flagged as 'beyond control.' Crude now $110–115 stable, but Middle East escalation is known risk.

Volume elasticity to stacked price hikes

Medium

Two price hikes in Nov (+10–12% total from March) test demand inelasticity at scale for first time. Paint 55%), so theory says demand inelastic. But 2–3 yrs price stability means behavior is unproven. Off-season (Nov–Dec) is wrong time to test.

Jodhpur plant execution delay

Medium

Trial late Sept, target end-Nov full ops. Automation is complex; timeline fuzzy ('may happen 10–15 days earlier'). Even 2–3 week delay pushes Q3 contribution to Q4, and Q3 margin recovery leans on Jodhpur not adding cost.

Monsoon product mix overhang extends

Medium

Q2 weakness in exterior paints (higher margin) due to monsoon. Management expects recovery in Q3 (festive season), but if monsoon extends or mix stays emulsion-heavy (lower margin), headwind persists into Q3.

Margin recovery contingent on macro, not just ops

Medium

H2 guidance explicitly hedged on 'crude $110–115' and 'no geopolitical flare-up.' Conditional outlook, not commitment. Removes confidence if macro shifts.

Inventory accounting volatility repeats

Low-Medium

If raw material prices spike again, new high-cost inventory creates another swing in future quarters. Swing is real (COGS), but masks operational trends. Investors need to normalize for this.

How the street is positioned

The stock trades at ₹900.45, down sharply from its all-time high of ₹3,329.95 (drawdown of 73%). It sits below key moving averages: ₹992.95 (20-day), ₹1,069.14 (50-day), ₹999.32 (200-day). RSI is 31.7 (neutral). Volume is rising, signaling either capitulation or emerging interest. On ownership, FII have been net sellers: down 1.68 pp to 5.73% in Q1 FY27 (from 7.41% in Q4 FY26). DII have added: +2.25 pp to 25.25%. Promoters hold steady at 53.88%. On Aug 14, HDFC Mutual Fund bulk-bought 5,80,947 shares at ₹1,173.26 — a vote of confidence at prices well above today. The drawdown is steep; the valuation reset harsh. Q2 miss (-47% PAT) has driven FII exit; October recovery narrative hasn't yet anchored rebound. If H2 proves the recovery story, the valuation gap vs. historic multiples could trigger re-entry for institutions.

What to watch next

Three things that resolve the debate by Q3 results (expected Jan 2027):
  • 1 · Jodhpur plant: full operational status by end-Nov

    Confirm 90KL plant running at intended capacity and margin-positive. Any delay or sub-capacity performance weakens H2 narrative. Track automation debugging daily for real-time progress.

  • 2 · Margin recovery in Q3 (Oct–Dec festive quarter)

    Look for EBITDA margin to expand materially from Q2 (8.6%) toward mid-teens. Driver: inventory clearing (done by Aug per mgmt), price-hike pass-through (Nov hikes), and mix recovery (festive season stronger in interior/premium). Flag October–November sales if disclosed.

  • 3 · Crude oil forward: watch for spike toward $120+

    If crude breaks $120, expect raw material re-acceleration and repeat high-cost inventory loading in Q3. $110–115 hold is green light; any jump is yellow flag for margin volatility.

Indigo Paints Q2 is a steady quarter hit by a temporary inventory timing shock. The company is not broken; it is in a margin compression cycle driven by raw material volatility and a deliberate strategy to pursue aggressive growth via price hikes and distribution. October's record sales claim, if sustained, validates H2 recovery. The real test is November and December: do price hikes hold volumes, does Jodhpur ramp as promised, and does crude stay stable? If all three check, the street's FII exit will look premature by Q3. If not, the case swings bear. The number to track from here is H2 EBITDA margin; hold mid-teens (15%+), and the thesis works. Miss it, and the debate reopens.

Informational and educational content only. Not investment advice.